Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
44 locations incl. Phoenix
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
Exelixis Clinical
Clinical research site in Omaha, Nebraska · 4924 CENTER ST, OMAHA, NE 68106-3219 · (402) 558-8888
Part of Exelixis Clinical
As of July 2026, 1 paid clinical trial is recruiting at Exelixis Clinical in Omaha, Nebraska. Active studies at this site cover conditions such as Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Urothelial Carcinoma (UC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Exelixis Clinical (1)
More research sites in Omaha
- University of Nebraska Medical Center (213 trials)
- Nebraska Cancer Specialists (37 trials)
- Nebraska Medicine-Village Pointe (36 trials)
- Children's Hospital and Medical Center of Omaha (29 trials)
- Alegent Health Bergan Mercy Medical Center (26 trials)
- Nebraska Methodist Hospital (26 trials)
- Alegent Health Immanuel Medical Center (23 trials)
- Alegent Health Lakeside Hospital (23 trials)
- Creighton University Medical Center (16 trials)
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC (16 trials)
Explore more
Paid clinical trials in Omaha, NE · Nebraska clinical trials